Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 03 1995, 525-527, Vol 33, No. 3
M Zrein, I Maure, F Boursier and L Soufflet
This work reports a comparison of an enzyme immunoassay (EIA) using two
major Treponema pallidum recombinant antigens with a T. pallidum
hemagglutination (TPHA) assay and a nontreponemal Venereal Disease
Reference Laboratory (VDRL) test. A total of 1,822 normal donor serum
samples was tested for cardiolipin and T. pallidum antibodies,
respectively, by the VDRL assay and EIA. Among these samples, 440 were
further tested by TPHA technology. Four samples were found positive by EIA,
while all were reported to be negative by both TPHA and VDRL routine
assays. Subsequent testing of EIA-positive samples confirmed 100% (four of
four samples) and 25% (one of four samples) positive results, respectively,
by immunofluorescence assay and a Western blot (immunoblot) syphilis kit.
The sensitivity of the recombinant EIA was estimated at virtually 100% with
a reference panel of 50 syphilitic samples. According to this study, the
newly developed EIA kit shows 100% sensitivity combined to a specificity
greater than 99.8% for detecting treponemal immunoglobulin G antibodies in
blood bank syphilis screening.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Recombinant antigen-based enzyme immunoassay for screening of Treponema pallidum antibodies in blood bank routine
Diagast Laboratories, Lille, France.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|